{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:39Z","timestamp":1791216519348,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.ejphar.2006.09.042","type":"journal-article","created":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T13:31:54Z","timestamp":1159536714000},"page":"171-184","source":"Crossref","is-referenced-by-count":76,"title":["Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: A comparison with diazepam and buspirone"],"prefix":"10.1016","volume":"553","author":[{"given":"Katsuya","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Aota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.09.042_bib1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0028-3908(95)00138-7","article-title":"Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera","volume":"34","author":"Abramowski","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2006.09.042_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-6147(00)88991-9","article-title":"5-HT2 receptor subtypes: a family re-united?","volume":"16","author":"Baxter","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2006.09.042_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0028-3908(97)00049-X","article-title":"RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist","volume":"36","author":"Bonhaus","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2006.09.042_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2007-1017385","article-title":"The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam","volume":"18","author":"Ceulemans","year":"1985","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2006.09.042_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00215473","article-title":"Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects","volume":"92","author":"Charney","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2006.09.042_bib6","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.09.042_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(87)90101-5","article-title":"Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission","volume":"8","author":"Chopin","year":"1987","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2006.09.042_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2006.09.042_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000284623","article-title":"Serotonin-1A anxiolytics: an overview","volume":"22","author":"Feighner","year":"1989","journal-title":"Psychopathology"},{"key":"10.1016\/j.ejphar.2006.09.042_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0270(80)90012-6","article-title":"The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs","volume":"2","author":"File","year":"1980","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2006.09.042_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0028-3908(94)90076-0","article-title":"Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects","volume":"33","author":"Gibson","year":"1994","journal-title":"Neuropharmacology"},{"issue":"Suppl 2","key":"10.1016\/j.ejphar.2006.09.042_bib12","first-page":"24","article-title":"Treating generalized anxiety disorder","volume":"64","author":"Gorman","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2006.09.042_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02247358","article-title":"5HT drugs in animal models of anxiety","volume":"112","author":"Handley","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2006.09.042_bib14","first-page":"157","article-title":"International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2006.09.042_bib15","first-page":"83","article-title":"A fully automated apparatus for a light\/dark test measuring anxiolytic or anxiogenic effects of drugs in mice","volume":"14","author":"Imaizumi","year":"1994","journal-title":"Jpn. J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2006.09.042_bib16","first-page":"968","article-title":"Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile","volume":"277","author":"Kehne","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.09.042_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02431539","article-title":"Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors","volume":"96","author":"Kennett","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2006.09.042_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1476-5381.1988.tb11508.x","article-title":"Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors","volume":"94","author":"Kennett","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.09.042_bib19","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1476-5381.1991.tb12369.x","article-title":"Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia","volume":"103","author":"Kennett","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.09.042_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0014-2999(89)90252-5","article-title":"Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists","volume":"164","author":"Kennett","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.09.042_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1476-5381.1994.tb14808.x","article-title":"In vivo properties of SB 200646A, a 5-HT2C\/2B receptor antagonist","volume":"111","author":"Kennett","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.09.042_bib21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","article-title":"SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2006.09.042_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0306-4522(90)90330-7","article-title":"The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution","volume":"35","author":"Mengod","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2006.09.042_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00001504-199703000-00006","article-title":"The adverse effects of antidepressants","volume":"10","author":"Mir","year":"1997","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.ejphar.2006.09.042_bib25","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1073\/pnas.86.17.6793","article-title":"5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system","volume":"86","author":"Molineaux","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2006.09.042_bib26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-61-6-1179","article-title":"Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans","volume":"61","author":"Mueller","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2006.09.042_bib27","first-page":"53","article-title":"A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety","volume":"51","author":"Murphy","year":"1990","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2006.09.042_bib28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4088\/JCP.v65n0903","article-title":"National trends in the outpatient treatment of anxiety disorders","volume":"65","author":"Olfson","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2006.09.042_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2006.09.042_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ejphar.2006.09.042_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s002130050406","article-title":"SSRI treatment decreases prolactin and hyperthermic responses to mCPP","volume":"133","author":"Quested","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2006.09.042_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00008877-199711000-00003","article-title":"Animal models of 'anxiety': where next?","volume":"8","author":"Rodgers","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.09.042_bib33","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-291X(91)92105-S","article-title":"Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes","volume":"181","author":"Saltzman","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.09.042_bib34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archpsyc.1997.01830200083012","article-title":"Noradrenergic and serotonergic function in posttraumatic stress disorder","volume":"54","author":"Southwick","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2006.09.042_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm00187a001","article-title":"The benzodiazepine story","volume":"22","author":"Sternbach","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2006.09.042_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(98)00223-4","article-title":"Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and\/or anxiolytic state in mice","volume":"350","author":"Takeda","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.09.042_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0091-3057(85)90438-1","article-title":"Pharmacological and clinical effects of buspirone","volume":"23","author":"Taylor","year":"1985","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2006.09.042_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1520-6394(1999)9:3<107::AID-DA2>3.0.CO;2-T","article-title":"International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992\u20131997. Depress","volume":"9","author":"Uhlenhuth","year":"1999","journal-title":"Anxiety"},{"key":"10.1016\/j.ejphar.2006.09.042_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0028-3908(01)00054-5","article-title":"SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety","volume":"41","author":"Wood","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2006.09.042_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0091-3057(91)90078-G","article-title":"A fully automated light\/dark apparatus useful for comparing anxiolytic agents","volume":"40","author":"Young","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2006.09.042_bib41","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.1987.01800230026006","article-title":"Serotonergic responsivity in obsessive\u2013compulsive disorder. Comparison of patients and healthy controls","volume":"44","author":"Zohar","year":"1987","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990601065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990601065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T20:27:30Z","timestamp":1547324850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990601065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":41,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S001429990601065X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.09.042","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}